Egypt Opens First Phase of Vaccine and Biotechnology City

Egyptian health authorities inaugurated the first phase of the Vaccine and Biotechnology City on Monday, marking a step toward expanding the country’s domestic pharmaceutical production capabilities.

The project aims to strengthen Egypt’s capacity to manufacture both human and veterinary vaccines, placing the needs of public and animal health within its production goals.

Reducing reliance on imported vaccines is a central objective. The initiative seeks to build local manufacturing capacity to support that shift.

Beyond production, the city is intended to establish a technological base that can underpin further expansion in vaccine manufacturing.

The project’s longer-term ambitions also include exports to overseas markets, positioning domestic production as a foundation for reaching customers beyond Egypt.